259 related articles for article (PubMed ID: 38191621)
1. hnRNP A1 dysfunction alters RNA splicing and drives neurodegeneration in multiple sclerosis (MS).
Salapa HE; Thibault PA; Libner CD; Ding Y; Clarke JWE; Denomy C; Hutchinson C; Abidullah HM; Austin Hammond S; Pastushok L; Vizeacoumar FS; Levin MC
Nat Commun; 2024 Jan; 15(1):356. PubMed ID: 38191621
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity to a ribonucleoprotein drives neuron loss in multiple sclerosis models.
Libner CD; Salapa HE; Hutchinson C; Stang TE; Thibault PA; Hammond SA; Levin MC
Neurobiol Dis; 2022 Aug; 170():105775. PubMed ID: 35618205
[TBL] [Abstract][Full Text] [Related]
3. Antibodies to the RNA binding protein heterogeneous nuclear ribonucleoprotein A1 contribute to neuronal cell loss in an animal model of multiple sclerosis.
Libner CD; Salapa HE; Hutchinson C; Lee S; Levin MC
J Comp Neurol; 2020 Jul; 528(10):1704-1724. PubMed ID: 31872424
[TBL] [Abstract][Full Text] [Related]
4. hnRNP A1 dysfunction in oligodendrocytes contributes to the pathogenesis of multiple sclerosis.
Jahanbazi Jahan-Abad A; Salapa HE; Libner CD; Thibault PA; Levin MC
Glia; 2023 Mar; 71(3):633-647. PubMed ID: 36382566
[TBL] [Abstract][Full Text] [Related]
5. Dysfunctional RNA binding proteins and stress granules in multiple sclerosis.
Salapa HE; Johnson C; Hutchinson C; Popescu BF; Levin MC
J Neuroimmunol; 2018 Nov; 324():149-156. PubMed ID: 30190085
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to the RNA-binding protein hnRNP A1 contribute to neurodegeneration in a model of central nervous system autoimmune inflammatory disease.
Douglas JN; Gardner LA; Salapa HE; Lalor SJ; Lee S; Segal BM; Sawchenko PE; Levin MC
J Neuroinflammation; 2016 Jul; 13(1):178. PubMed ID: 27391474
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to the RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein A1 Colocalize to Stress Granules Resulting in Altered RNA and Protein Levels in a Model of Neurodegeneration in Multiple Sclerosis.
Douglas JN; Gardner LA; Salapa HE; Levin MC
J Clin Cell Immunol; 2016 Apr; 7(2):402. PubMed ID: 27375925
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous nuclear ribonucleoprotein A1 in health and neurodegenerative disease: from structural insights to post-transcriptional regulatory roles.
Bekenstein U; Soreq H
Mol Cell Neurosci; 2013 Sep; 56():436-46. PubMed ID: 23247072
[TBL] [Abstract][Full Text] [Related]
9. Heterogeneous Nuclear Ribonucleoprotein A1 (hnRNP A1) and hnRNP A2 Inhibit Splicing to Human Papillomavirus 16 Splice Site SA409 through a UAG-Containing Sequence in the E7 Coding Region.
Zheng Y; Jönsson J; Hao C; Shoja Chaghervand S; Cui X; Kajitani N; Gong L; Wu C; Schwartz S
J Virol; 2020 Sep; 94(20):. PubMed ID: 32759322
[TBL] [Abstract][Full Text] [Related]
10. Computer-Aided Discovery of Small Molecules Targeting the RNA Splicing Activity of hnRNP A1 in Castration-Resistant Prostate Cancer.
Carabet LA; Leblanc E; Lallous N; Morin H; Ghaidi F; Lee J; Rennie PS; Cherkasov A
Molecules; 2019 Feb; 24(4):. PubMed ID: 30791548
[TBL] [Abstract][Full Text] [Related]
11. Knock-Down of Heterogeneous Nuclear Ribonucleoprotein A1 Results in Neurite Damage, Altered Stress Granule Biology, and Cellular Toxicity in Differentiated Neuronal Cells.
Anees A; Salapa HE; Thibault PA; Hutchinson C; Hammond SA; Levin MC
eNeuro; 2021; 8(6):. PubMed ID: 34697074
[TBL] [Abstract][Full Text] [Related]
12. hnRNP A1 Regulates Alternative Splicing of Tau Exon 10 by Targeting 3' Splice Sites.
Liu Y; Kim D; Choi N; Oh J; Ha J; Zhou J; Zheng X; Shen H
Cells; 2020 Apr; 9(4):. PubMed ID: 32290247
[TBL] [Abstract][Full Text] [Related]
13. HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395.
Sun G; Zhou H; Chen K; Zeng J; Zhang Y; Yan L; Yao W; Hu J; Wang T; Xing J; Xiao K; Wu L; Ye Z; Xu H
J Exp Clin Cancer Res; 2020 Jun; 39(1):116. PubMed ID: 32560659
[TBL] [Abstract][Full Text] [Related]
14. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
[TBL] [Abstract][Full Text] [Related]
15. Neuronal RNA-binding protein dysfunction in multiple sclerosis cortex.
Salapa HE; Hutchinson C; Popescu BF; Levin MC
Ann Clin Transl Neurol; 2020 Jul; 7(7):1214-1224. PubMed ID: 32608162
[TBL] [Abstract][Full Text] [Related]
16. Position-dependent effects of hnRNP A1/A2 in SMN1/2 exon7 splicing.
Qiu J; Qu R; Lin M; Xu J; Zhu Q; Zhang Z; Sun J
Biochim Biophys Acta Gene Regul Mech; 2022 Nov; 1865(8):194875. PubMed ID: 36208849
[TBL] [Abstract][Full Text] [Related]
17. A truncated hnRNP A1 isoform, lacking the RGG-box RNA binding domain, can efficiently regulate HIV-1 splicing and replication.
Jean-Philippe J; Paz S; Lu ML; Caputi M
Biochim Biophys Acta; 2014; 1839(4):251-8. PubMed ID: 24530421
[TBL] [Abstract][Full Text] [Related]
18. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
[TBL] [Abstract][Full Text] [Related]
19. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
[TBL] [Abstract][Full Text] [Related]
20. Global identification of hnRNP A1 binding sites for SSO-based splicing modulation.
Bruun GH; Doktor TK; Borch-Jensen J; Masuda A; Krainer AR; Ohno K; Andresen BS
BMC Biol; 2016 Jul; 14():54. PubMed ID: 27380775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
